Julie O'Neill
2017
In 2017, Julie O'Neill earned a total compensation of $4.7M as Former Executive Vice President of Global Operations at Alexion Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $715,225 |
|---|---|
| Option Awards | $656,276 |
| Salary | $651,471 |
| Stock Awards | $2,491,537 |
| Other | $136,817 |
| Total | $4,651,326 |
O'Neill received $2.5M in stock awards, accounting for 54% of the total pay in 2017.
O'Neill also received $715.2K in non-equity incentive plan, $656.3K in option awards, $651.5K in salary and $136.8K in other compensation.
Rankings
In 2017, Julie O'Neill's compensation ranked 2,089th out of 14,666 executives tracked by ExecPay. In other words, O'Neill earned more than 85.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,089 out of 14,666 | 86th |
Division Manufacturing | 716 out of 5,772 | 88th |
Major group Chemicals And Allied Products | 193 out of 2,075 | 91st |
Industry group Drugs | 146 out of 1,731 | 92nd |
Industry Pharmaceutical Preparations | 113 out of 1,333 | 92nd |
Source: SEC filing on March 26, 2019.
O'Neill's colleagues
We found five more compensation records of executives who worked with Julie O'Neill at Alexion Pharmaceuticals in 2017.
2017
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2017
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2017
Brian Goff
Alexion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2017
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research & Development
2017
Anne-Marie Law
Alexion Pharmaceuticals